Electra Therapeutics Inc. (ETRA) vs Prelude Therapeutics Incorporated (PRLD)

A side-by-side comparison of Electra Therapeutics Inc. and Prelude Therapeutics Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETRA

Electra Therapeutics Inc.

$208M

$9.82HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PRLD

Prelude Therapeutics Incorporated

$217M

$3.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ETRA vs PRLD

growth of $100 · dividends reinvested · last 1y

ETRA -26.5% (-26.5%/yr)PRLD -17.5% (-17.5%/yr)PRLD compounded faster over this window

ETRA PRLD

Metrics side by side

Total return (annualized)

Metric	ETRA	PRLD
Total return (1Y)	N/A	155.31%
Total return CAGR (3Y)	N/A	10.69%
Total return CAGR (5Y)	N/A	-33.98%

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ETRA analysis Full PRLD analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.